HIGHLIGHTS
- who: Betzabel N. Cajiao Garcia from the University of Groningen, University Medical Center Groningen, Department of Pathology and Medical Biology, Groningen, The Netherlands have published the paper: Prevalence of KRAS p.(G12C) in stage IV NSCLC patients in the Netherlands; a nation-wide retrospective cohort study, in the Journal: (JOURNAL)
- what: The aim of this study was to establish the prevalence of KRAS p.(G12C) mutations in the Netherlands for stage-IV non-squamous NSCLC patients to determine the impact of the pending EMA approval of sotorasib and other KRAS p.(G12C) inhibitors.
-
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.